Ultragenyx Pharmaceutical Investor Relations Material
Latest events
Q1 2025
Ultragenyx Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ultragenyx Pharmaceutical Inc
Access all reports
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare and ultra-rare genetic diseases. The company's focus includes treatments for metabolic disorders, bone diseases, and other conditions with significant unmet medical needs. Ultragenyx leverages innovative research and targeted approaches to address complex diseases that often lack effective therapies.The company is headquartered in Novato, California, and its shares are listed on the NASDAQ.
Key slides for Ultragenyx Pharmaceutical Inc
Q1 2025
Ultragenyx Pharmaceutical Inc
Q2 2024
Ultragenyx Pharmaceutical Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RARE
Country
🇺🇸 United States